ICARES Medicus, Inc. (TPEX:6612)

ICARES Medicus Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,081	859.79	605.45	511.85	393.92	362.67
Revenue Growth (YoY)	67.55%	42.01%	18.29%	29.94%	8.62%	-13.52%
Cost of Revenue	415.41	260.06	123.05	94.41	71.04	70.8
Gross Profit	665.29	599.73	482.4	417.44	322.89	291.87
Selling, General & Admin	331.02	277.97	186.31	157.23	127	116.32
Research & Development	176.4	192.7	177.45	133.08	104.87	98.25
Operating Expenses	512.24	476.48	373.84	292.73	235.03	213.36
Operating Income	153.05	123.25	108.56	124.71	87.85	78.52
Interest Expense	-24.72	-18.33	-7.17	-0.58	-0.83	-0.98
Interest & Investment Income	41.66	44.45	5.29	2.67	2.48	1.5
Earnings From Equity Investments	9.03	2.38	-1.35	-4.18	-2.17	-5.46
Currency Exchange Gain (Loss)	8.64	8.64	0.93	15.72	-4.81	-6.43
Other Non Operating Income (Expenses)	-52.66	5.18	4.56	5.1	3.99	2.6
EBT Excluding Unusual Items	135	165.58	110.82	143.44	86.51	69.74
Gain (Loss) on Sale of Investments	-1.17	-1.17	2.47	-0.33	-13.32	-
Gain (Loss) on Sale of Assets	-	-	-	-	-	4.02
Pretax Income	133.83	164.4	113.29	143.11	73.19	73.76
Income Tax Expense	82.46	109.89	48.86	32.72	35.82	36.84
Earnings From Continuing Operations	51.37	54.51	64.43	110.39	37.37	36.93
Minority Interest in Earnings	42.9	48.61	33.3	18.52	21.23	14.98
Net Income	94.26	103.12	97.73	128.91	58.6	51.91
Net Income to Common	94.26	103.12	97.73	128.91	58.6	51.91
Net Income Growth	33.99%	5.52%	-24.19%	119.97%	12.90%	-35.93%
Shares Outstanding (Basic)	43	43	38	37	37	37
Shares Outstanding (Diluted)	43	43	39	37	37	37
Shares Change (YoY)	3.56%	11.53%	2.91%	0.74%	0.38%	0.39%
EPS (Basic)	2.22	2.41	2.55	3.46	1.58	1.41
EPS (Diluted)	2.20	2.40	2.54	3.45	1.58	1.40
EPS Growth	29.09%	-5.51%	-26.28%	117.82%	12.99%	-36.36%
Free Cash Flow	-88.59	-159.8	-96.74	97.47	33.18	62.26
Free Cash Flow Per Share	-2.07	-3.72	-2.51	2.60	0.89	1.68
Dividend Per Share	0.300	0.300	0.182	0.909	0.455	0.091
Dividend Growth	65.02%	65.02%	-80.00%	100.02%	400.00%	-80.00%
Gross Margin	61.56%	69.75%	79.68%	81.56%	81.97%	80.48%
Operating Margin	14.16%	14.34%	17.93%	24.37%	22.30%	21.65%
Profit Margin	8.72%	11.99%	16.14%	25.19%	14.88%	14.31%
Free Cash Flow Margin	-8.20%	-18.59%	-15.98%	19.04%	8.42%	17.17%
EBITDA	251.52	180.13	129.33	142.69	106.87	99.58
EBITDA Margin	23.27%	20.95%	21.36%	27.88%	27.13%	27.46%
D&A For EBITDA	98.47	56.87	20.77	17.97	19.02	21.07
EBIT	153.05	123.25	108.56	124.71	87.85	78.52
EBIT Margin	14.16%	14.34%	17.93%	24.37%	22.30%	21.65%
Effective Tax Rate	61.62%	66.84%	43.13%	22.86%	48.94%	49.94%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.